ERLOTINIB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 22 adverse event reports in the FDA FAERS database where ERLOTINIB was used for Prostate cancer.
Most Reported Side Effects for ERLOTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 5,000 | 22.3% | 4,996 | 386 |
| Rash | 4,648 | 20.7% | 580 | 485 |
| Diarrhoea | 3,448 | 15.3% | 462 | 598 |
| Fatigue | 1,548 | 6.9% | 392 | 246 |
| Nausea | 1,366 | 6.1% | 284 | 290 |
| Drug ineffective | 1,207 | 5.4% | 159 | 101 |
| Off label use | 1,190 | 5.3% | 809 | 198 |
| Decreased appetite | 998 | 4.4% | 249 | 234 |
| Malignant neoplasm progression | 954 | 4.3% | 494 | 230 |
| Dry skin | 953 | 4.2% | 57 | 83 |
| Disease progression | 910 | 4.1% | 246 | 93 |
| Pruritus | 830 | 3.7% | 68 | 82 |
| Vomiting | 820 | 3.7% | 199 | 271 |
| Asthenia | 757 | 3.4% | 281 | 230 |
| Dyspnoea | 738 | 3.3% | 265 | 283 |
Other Indications for ERLOTINIB
Lung neoplasm malignant (9,207)
Non-small cell lung cancer (3,359)
Product used for unknown indication (3,040)
Pancreatic carcinoma (1,089)
Malignant respiratory tract neoplasm (876)
Lung adenocarcinoma (841)
Neoplasm malignant (565)
Bronchial carcinoma (397)
Non-small cell lung cancer metastatic (290)
Lung adenocarcinoma stage iv (203)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)